Western blot analysis for an additional auto-phosphorylation site of the EGFR, residue Y1092, showed higher levels of phosphorylation in Smarcb1 deficient tumor cells compared with Smarcb1 proficient cells under low serum. Here, SMARCB1 is linked to neoplasm.